Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹641.15
18.80 (3.02%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹5.81K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
31.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹585+9.6%
52W High₹971-34.0%
Current Price
₹641.15
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹512.92
Upper Circuit₹769.38
Reference Price
₹641.15
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹678.1
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹628.4
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -42.86 (SELL) with 50.2% confidence
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
50%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
655.64
EMA50
677.95
EMA200
746.39
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹670.88
₹687.05
₹694.00
₹711.00
₹726.78
Support (Below)
₹624.55
₹585.00
Volume Analysis
TrendDECREASING
Change-12.00%
Unusual VolumeNo
Recent Price Gaps
Gap Down
5 days ago • 0.23%(Filled)
BEARISH
Stop Loss Levels
Fixed Risk
1% Risk₹634.74
3% Risk₹621.92
5% Risk₹609.09
7% Risk (Custom)
₹596.27Technical Levels
1x ATR (Volatility)₹614.79
2x ATR (Swing)₹588.43
3x ATR (Trend)₹562.07
Immediate Support₹624.55
Moving Averages
EMA 9 (Short-term)₹634.56
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹534.7 Cr | ₹386.2 Cr | ₹418.3 Cr | ₹432.3 Cr |
| Net Profit | ₹88.3 Cr | ₹49.5 Cr | ₹27.9 Cr | ₹48 Cr |
| EPS | — | ₹5.46 | ₹3.08 | ₹5.29 |
| Operating Profit | ₹144 Cr | ₹95 Cr | ₹74.1 Cr | ₹104.1 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 16 Feb 2026 | Interim Dividend - Rs 1.50 Per Share | INTERIM_DIVIDEND |
| 15 Sept 2025 | Dividend - Rs 2.50 Per Share | DIVIDEND |
| 14 Feb 2025 | Interim Dividend - Rs 2.50 Per Share | INTERIM_DIVIDEND |
| 31 Jul 2024 | Dividend - Re 1 Per Share | DIVIDEND |
| 16 Feb 2024 | Interim Dividend - Rs 2 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AARTIPHARM
View AllNEWS
negative
Business Standard - Markets 18d ago
Techno Electric & Engineering Company Ltd leads losers in 'A' group
Container Corporation Of India Ltd, Poly Medicure Ltd, Aarti Pharmalabs Ltd and Le Travenues Technology Ltd are among the other losers in the BSE's 'A' group today, 26 May 2026.
AARTIINDAARTIPHARMBSECONCORHGINFRAIXIGOMBELPOLYMEDSALASARTECHNOECapital GoodsChemicals
positive
CNBC TV18 - Markets 18d ago
Aarti Pharmalabs Q4 Results: Shares slide 6% as forex loss, one-offs impact earnings performance
Aarti Pharmalabs recognised fair value losses related to a target redemption forward contract entered into during FY25 for hedging anticipating US dollar export inflows. The total fair value impact recognised in FY26 stood at ₹29.7 crore.
AARTIINDAARTIPHARMAONETMMQ50AONETOTALDOLLARTOTALVALUEChemicalsFinancial Services
NEWS
positive
Business Standard - Markets 18d ago
Aarti Pharmalabs consolidated net profit declines 30.81% in the March 2026 quarter
Sales rise 3.35% to Rs 582.64 crore
AARTIINDAARTIPHARMChemicalsHealthcare